founder & CEO of AffyImmune Therapeutics, based in Newton Centre, Massachusetts
AffyImmune Therapeutics is a clinical-stage biotechnology company focusing on the optimization of CAR T cells for the treatment of solid tumors using thier Tune & Track platform.